10-Q: 3D Systems Reports Q1 2026 Results, Revenue Up Slightly

3D Systems Corporation announced its first quarter 2026 financial results, showing a modest increase in total revenue driven by product sales, while navigating operational efficiencies and ongoing legal matters.

Summary

• Total revenue for the first quarter of 2026 was $95.5 million, a 1.1% increase compared to $94.5 million in the first quarter of 2025.
• Product revenue increased by $3.0 million, attributed to higher materials and printer volume in dental and aerospace/defense markets, and a favorable foreign currency impact.
• Service revenue decreased by $2.0 million, mainly due to divestitures, partially offset by increases in parts manufacturing.
• Gross profit increased by 5.1% to $34.3 million, with a gross profit margin of 35.9%, up from 34.6% in the prior year period.
• Operating expenses saw a significant decrease, with SG&A down 37.0% to $31.3 million and R&D down 51.0% to $9.6 million, largely due to restructuring actions and divestitures.
• The company reported a net loss attributable to 3D Systems Corporation of $4.4 million, or $0.03 per diluted share, an improvement from a net loss of $37.0 million, or $0.28 per diluted share, in the prior year period.
• Cash and cash equivalents decreased to $85.1 million from $95.6 million at the end of 2025, primarily due to cash used in operations and capital expenditures.
• The company is actively addressing material weaknesses in internal controls over financial reporting through a remediation plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, with improvements in profitability metrics and revenue growth, but still burdened by a net loss and ongoing legal challenges.

Positives

• Revenue increased by 1.1% to $95.5 million in Q1 2026 compared to Q1 2025.
• Gross profit increased by 5.1% to $34.3 million, with gross profit margin improving to 35.9% from 34.6%.
• Significant reduction in operating expenses: SG&A decreased by 37.0% and R&D decreased by 51.0%.
• Healthcare Solutions segment revenue grew by 21.3% to $50.1 million, with gross profit increasing by 39.1%.
• Net loss attributable to 3D Systems Corporation improved significantly to $4.4 million from $37.0 million in the prior year.
• The company's export control settlement with government agencies was closed in February 2026.
• The company is compliant with financial covenants under its 2030 Indenture.

Negatives

• Service revenue decreased by $2.0 million due to divestitures.
• Industrial Solutions segment revenue decreased by 14.7% to $45.4 million.
• The company reported a net loss of $4.4 million for the quarter.
• Cash and cash equivalents decreased by $10.6 million during the quarter.
• The company continues to face significant legal proceedings, including a securities class action and derivative lawsuits.
• Material weaknesses in internal controls over financial reporting persist.

Risks

• Macroeconomic events, geopolitical risks, supply chain disruptions, inflation, interest rates, and foreign exchange volatility could impact business.
• The company's ability to deliver products that meet changing technology and customer needs.
• Risks associated with strategic acquisitions, integration, and realization of benefits.
• Potential write-off or write-down of goodwill and intangible assets.
• Concentration of revenue and credit risk exposure from its largest customer.
• Ability to acquire, enforce, and defend intellectual property rights.
• Failure of IT infrastructure or inability to protect against cyber-attacks.
• Difficulty in predicting quarterly sales and managing inventory due to uneven sales cycles.
• Ability to generate net cash flow from operations and service debt, including potential cash needs for convertible note conversions or maturities.
• Compliance with debt covenants, which could restrict business operations.
• Challenges in remediating material weaknesses in internal controls over financial reporting.
• Fluctuations in gross profit margins, operating income/loss, and net income/loss.
• Dependence on supply chain for components, sub-assemblies, and raw materials.
• Costs and effects of litigation, investigations, or similar matters.
• Product quality issues leading to decreased sales, returns, or liability claims.
• Ability to retain key employees and attract new qualified employees.
• Challenges in developing and commercializing regenerative medicine products.
• Disruption in management information systems.
• Compliance with anti-corruption laws, data privacy laws, trade controls, and economic sanctions.
• Maintaining status as a responsible contractor under federal rules.
• Changes in tax rules and regulations.
• The ongoing securities class action and derivative lawsuits pose significant legal and financial risks.

Future Outlook

The company expects that cash flow from operations, cash and cash equivalents, and other sources of liquidity, such as issuing equity or debt securities, subject to market conditions, will be available and sufficient to meet all its cash requirements over the next twelve months. Future cash requirements beyond the next twelve months will depend on profitability, working capital management, and the ability to secure other funding sources.

Management Comments

• Management believes that the disclosures included in this Form 10-Q are adequate to make the information presented not misleading.
• Management believes that the Company has the financial resources needed to meet its anticipated cash requirements during the next twelve months.
• Management may consider pursuing additional long-term financing if it is appropriate in light of cash requirements for operations or strategic opportunities, which could result in higher financing costs.

Industry Context

StockSavvy.ai notes that 3D Systems' Q1 2026 results reflect a challenging but stabilizing environment for the additive manufacturing sector. The company's strategic focus on its Healthcare Solutions segment, which showed strong growth, and the divestiture of non-core assets like Geomagic, 3DXpert, and Oqton, indicate a strategic pivot towards higher-margin, specialized applications. The significant reduction in operating expenses, particularly R&D and SG&A, suggests a focus on operational efficiency and profitability, which is a broader trend across the industry as companies mature and seek sustainable growth.

Comparison to Industry Standards

• While specific direct competitors' Q1 2026 results are not provided in this filing, 3D Systems' reported gross profit margin of 35.9% is within the typical range for established players in the industrial and healthcare additive manufacturing space. Companies like Stratasys and Desktop Metal often report margins in the 30-50% range, depending on product mix and segment focus.
• The reported net loss of $4.4 million, while negative, represents a significant improvement from the prior year's loss of $37.0 million. This trend of reducing losses and moving towards profitability is a key focus for many companies in the capital-intensive 3D printing industry, which has seen consolidation and strategic realignments.
• The substantial decrease in R&D spending (51.0%) and SG&A (37.0%) suggests a more disciplined approach to cost management, which is becoming increasingly important for investors evaluating the sector's path to sustainable profitability. This contrasts with earlier growth phases where aggressive R&D investment was prioritized.

Legal Proceedings

• SEC formal investigation ongoing since April 15, 2022, related to allegations in a 2021 securities class action lawsuit.
• Securities Class Action lawsuit filed on June 13, 2025, alleging violations of the Securities Exchange Act of 1934 and SEC Rule 10b-5.
• Consolidated Derivative Actions pending in the District of South Carolina (Scanlon, Milligan, Stoopler) and the State of South Carolina (Fernicola, Bohus).
• Consolidated Derivative Actions pending in the District of Delaware (Ataii, Carter, Michaels).
• 3D Systems, Inc. initiated a lawsuit against five former employees and Intrepid Automation, Inc. in May 2021, alleging theft of trade secrets and unfair competition. Intrepid filed counterclaims, and a trial on these counterclaims is scheduled for July 27, 2026.
• Intrepid Automation filed a lawsuit in December 2024 alleging infringement of U.S. patents; the lawsuit is stayed pending USPTO review of inter partes review petitions.

Related Party Transactions

• The Company made purchases from Enhatch Inc. of $0.4 million during the three months ended March 31, 2026.
• The Company provided financing of $1.0 million to Hull Legacy Media Corporation, a production company co-owned by Charles W. Hull, EVP, Chief Technology Officer for the Company's Regenerative Medicine business.

Stakeholder Impact

• Shareholders: The net loss and ongoing legal proceedings may impact share price and investor confidence. However, the improvement in net loss and revenue growth could be viewed positively.
• Employees: Restructuring actions and cost reductions may impact workforce size and morale. Retention of key employees is noted as a risk.
• Creditors: The company's compliance with debt covenants is positive, but the ongoing net loss and cash burn could be a concern for debt holders.
• Customers: Continued product development and service offerings are crucial. The company's focus on Healthcare Solutions may benefit customers in that sector.

Next Steps

• Continue to implement the 2025 Restructuring Plan to deliver sustainable growth and profitability.
• Invest in core research and development activities to support long-term growth opportunities.
• Continue to remediate material weaknesses in internal controls over financial reporting.
• Defend vigorously against ongoing legal proceedings, including the securities class action and derivative lawsuits.
• Monitor and manage cash flow to meet operational and capital expenditure requirements.
• Potentially pursue additional long-term financing if deemed appropriate.

Key Dates

Recommendation

The company shows signs of operational improvement with increased revenue and reduced losses, driven by cost-cutting and strategic divestitures. However, the persistent net loss, significant ongoing legal challenges (including class action and derivative suits), and the need to remediate internal control weaknesses introduce considerable uncertainty. While the Healthcare Solutions segment is performing well, the Industrial Solutions segment is declining, and the overall financial health requires further stabilization. A 'hold' recommendation reflects a balanced view of the potential for recovery against the substantial risks.

Keywords

3D Systems, Form 10-Q, Quarterly Report, 3D printing, Digital manufacturing, Healthcare Solutions, Industrial Solutions, Revenue, Net Loss, Financial Results, SEC Filing